In vitro antiglycation activity of Eremurus persicus (Jaub. Et Sp.) Boiss

African Journal of Biotechnology

Volumn 10, Issue 54, 2011, Pages 11287-11289

  Asgarpanah, Jinous ^a   Amin, Gholamreza ^b   Parviz, Malihe ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5,6,7 trimethoxy coumarin; Antiglycation; Eremurus persicus

Indexed keywords

5,6,7 TRIMETHOXYCOUMARIN; ADVANCED GLYCATION END PRODUCT; EREMURUS PERSICUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIGLYCATION ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTALLIZATION; DRUG ACTIVITY; DRUG STRUCTURE; EREMURUS PERSICUS; GLYCATION; IN VITRO STUDY; MEDICINAL PLANT; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EREMURUS;

EID: 80053078510     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/ajb11.672     Document Type: Article

References (7)

1. Aronson D (2003). Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffness of aging and diabetes. J. Hypertention, 21: 3-12.
2. Jedsadayanmata A (2005). In vitro antiglycation activity of arbutin, Pharmacol. Res. 13(2): 35-41.
3. Muhammad Saeed A, Nessar A (2006). Antiglycation properties of aged garlic extract: role in prevention of diabetic complications. J. Nutr., 3: p. 3.
4. Rahbar S, Figarola JL (2003). Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 63-79.
5. Singh R, Barden A, Mori T, Beilin L (2001). Advanced glycation endproducts: A review, Diabetologia, 44: 129-146.
6. Ulrich P, Cerami A (2001). Protein glycation, diabetes and aging. Recent Progress Hormone Res. 56: 1-21.
7. Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG (2003). Modification of proteins in vitro by physiological levels of glucose, J. Biol. Chem. 278: 46616-46624.